Tag: Alzheimers
The United States authorizes a long-awaited new treatment for Alzheimer’s
US health authorities on Friday authorized a new Alzheimer’s drug aimed at reducing cognitive decline in patients suffering from this neurodegenerative disease, a much-awaited treatment after the failed launch of…
New drugs for Alzheimer’s: what they do
The American regulatory authority FDA has again approved a drug for Alzheimer’s. This could also be available in Europe in 2023. We answer the most important questions about the medication.…
Alzheimer’s: researchers are developing a test that could revolutionize the detection of the disease
Florent Lanne December 29, 2022 at 11:30 a.m. 12 © Anna Shvets / Pexels Scientists have developed a blood test capable of detecting Alzheimer’s disease. This is neither more nor…
Roche: FDA authorization for Alzheimer’s tests
(CercleFinance.com) – Roche today announced that its Elecsys ® beta-Amyloid (1-42) CSF II (Abeta42) and Elecsys ® Phospho -Tau (181P) CSF (pTau181) test products have received regulatory approval. United States…
Drug against Alzheimer’s – Alzheimer’s research: A little bit of progress – knowledge
contents A new Alzheimer’s drug raises hopes that the disease can be slowed down at an early stage. But the drug can have serious side effects. Will there be an…
MEDESIS PHARMA PRESENTS A SCIENTIFIC POSTER AT THE CLINICAL TRIALS ON ALZHEIMER’S DISEASE CONFERENCE IN SAN FRANCISCO – 11/28/2022 at 6:00 PM
Montpellier, November 28, 2022 at 6:00 p.m. – MEDESIS PHARMA, a pharmaceutical biotechnology company developing drug candidates based on its proprietary technology for the administration of active ingredients in nano…
These researchers have made an important discovery in the fight against Alzheimer’s
Researchers from Rouen and Lille have identified genes that would increase the risk of developing this neurodegenerative disease, according to 76 news. By ThePoint.fr This discovery “confirms that we are…
AB Science: green light from the FDA for a confirmatory phase 3 study with masitinib in Alzheimer’s disease
By Olivier Cheilan Posted on 11/21/2022 at 6:29 p.m. (Boursier.com) —…
AB Science: Receives FDA Approval in Alzheimer’s
(CercleFinance.com) – AB Science SA announces today that its phase III clinical study (AB21004) in mild to moderate Alzheimer’s disease has been approved by the US Food and Drug Administration…
AB Science: Receives FDA Approval in Alzheimer’s – 11/21/2022 at 6:33 pm
(CercleFinance.com) – AB Science SA announces today that its phase III clinical study (AB21004) in mild to moderate Alzheimer’s disease has been approved by the US Food and Drug Administration…
Alzheimer’s: New Roche drug does not work
Similar means from other companies have so far hardly shown any real improvements in the everyday life of those affected. But don’t write off the funds just yet. This image…
No remedy for Alzheimer’s – Desperate search for Alzheimer’s drug continues – News
contents The pharmaceutical industry has poured tens of billions into Alzheimer’s research and testing for years. Almost unsuccessful so far. Normally, pharmaceutical companies have to invest roughly one to 2.5…